Surrozen, Inc. (NASDAQ:SRZNW) Sees Large Decrease in Short Interest

Surrozen, Inc. (NASDAQ:SRZNW) was the recipient of a significant decrease in short interest in April. As of April 15th, there was short interest totalling 11,800 shares, a decrease of 42.2% from the March 31st total of 20,400 shares. Based on an average daily trading volume, of 2,900 shares, the days-to-cover ratio is presently 4.1 days.

Surrozen Price Performance

Shares of SRZNW stock remained flat at $0.02 on Friday. The firm has a 50 day simple moving average of $0.04 and a 200-day simple moving average of $0.03. Surrozen has a 12 month low of $0.01 and a 12 month high of $0.12.

About Surrozen

Surrozen, Inc, a clinical stage biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. The company is developing antibody-based therapeutics with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system.